T790M mutations identified by circulating tumor DNA test in lung adenocarcinoma patients who progressed on first-line epidermal growth factor receptor-tyrosine kinase inhibitors.

Merinda, Vinodini; Soegiarto, Gatot; Wulandari, Laksmi

Merinda, Vinodini; Soegiarto, Gatot; Wulandari, Laksmi.

Afiliação

Merinda V; Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Soegiarto G; Division of Clinical Immunology, Department of Internal Medicine, Faculty of Medicine Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
Wulandari L; Division of Thoracic Oncology, Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.

Lung India ; 37(1): 13-18, 2020.

Article em En | MEDLINE | ID: mdl-31898615

Palavras-chave

T790M mutation; first-line epidermal growth factor receptor-tyrosine kinase inhibitors; lung adenocarcinoma; plasma circulating tumor deoxyribonucleic acid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Lung India Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google